Applications in Internet Time, LLC v. Salesforce, Inc.

District Court, D. Nevada·Decided November 9, 2021·No. 3:13-cv-00628·Unknown

Opinion

LLC, ) ) Plaintiff, ) ) 3:13-cv-00628-RCJ-CLB ) vs. ) ORDER ) SALESFORCE.COM, Inc., ) ) Defendant. ) )

On November 8, 2013, Plaintiff Applications in Internet Time, LLC (“AIT”) brought this suit against Defendant Salesforce.com, Inc. (“Salesforce”) alleging infringement of two patents that AIT owns: U.S. Patent No. 7,356,482 (“‘482 patent”) and U.S. Patent No. 8,484,111 (“‘111 patent”). The parties have submitted several claim terms on which they dispute the proper construction and/or whether are indefinite. After full briefing, this Court held a Markman hearing whereby it heard all the issues pertaining to the construction of these terms, on August 23, 2021. The Court now addresses these arguments. In 2014, Salesforce answered and brought counterclaims seeking to invalidate both patents. Salesforce also filed petitions for covered business method patent review (CBM) with the United States Patent & Trademark Office’s Patent Trial and Appeal Board (PTAB) challenging the validity of the patents in suit here, Salesforce moved for a stay of this suit pending resolution of the CBMs. AIT stipulated to the stay, and the Court stayed the proceedings on August 25, 2014. On April 27, 2015, after the PTAB denied Salesforce’s petitions for CBM, the Court lifted the stay. The parties then began briefing claim construction, beginning with a Joint Claim Construction and Prehearing Statement (ECF No. 63) and AIT’s opening claim construction brief (ECF No. 65). Then, on October 9, 2015, Salesforce filed a second motion to stay (ECF No. 66) pending inter partes review (IPR) filed with the PTAB by RPX Corporation (“RPX”) challenging the validity of the patents-in-suit here. In October 2015, Salesforce filed its responsive claim construction brief, and AIT replied. (ECF Nos. 67, 74.) The Court denied the motion to stay without prejudice because the PTAB had not yet instituted the RPX’s petitions for IPR. (ECF No. 76.) On March 30, 2016, Salesforce renewed the

motion because the PTAB had instituted RPX’s petitions for IPR. (ECF No. 77.) AIT opposed this renewed motion on April 13, 2016 (ECF No. 78), and Salesforce replied on April 20, 2016. (ECF No. 80.) On June 14, 2016, the Court granted Salesforce’s renewed motion and stayed the action. (ECF No. 82.) On December 28, 2016, the PTAB entered final written decisions (FWDs) in the IPR proceedings concluding that the challenged claims of the two patents-in=suit are unpatentable. On July 9, 2018, after AIT appealed the PTAB’s final written decisions, the Court of Appeals for the Federal Circuit vacated the FWDs and remanded to the PTAB. On August 8, 2018, the Court ordered a status conference for September 17, 2018. (ECF No. 87.) On September 7, 2018, RPX petitioned the Federal Circuit for rehearing en banc. On

September 17, 2018, the Court conducted a status conference and therein ordered that the stay of /// the case be kept in place. The Court further ordered the parties to file status reports regarding the PTAB’s IPR proceedings every six months. (ECF No. 96.) On October 30, 2018, the Federal Circuit issued its formal mandate to the PTAB in accordance with its July 9, 2018 judgment. On January 15, 2019, AIT’s ’111 patent expired. On April 25, 2019, with all briefing complete, the PTAB held an oral hearing on whether Salesforce is a real party-in-interest or privy of RPX. On August 27, 2019, AIT filed a motion to lift stay and expedite proceedings. (ECF No. 105.) On September 10, 2019, Salesforce filed an opposition to the motion. (ECF No. 109.) On September 17, 2019, AIT filed a reply in support of the motion. (ECF No. 110.) On November 25, 2019, while the motion was pending in this Court, AIT emailed the PTAB, with copies to RPX (the opposing party), inquiring: 1) as to the status of the case; and 2) as to whether a panel reassignment will issue. Specifically, AIT inquired whether a decision on

the remand was going to issue in the near term and whether, in light of the Federal Circuit’s decision in Arthrex, Inc. v. Smith & Nephew, Inc. Case No. 2018-2140, October 31, 2019, the case could or should be reassignment to a different panel. On November 27, 2019, the PTAB responded to all counsel that “the decision on remand will issue in due course.” On January 7, 2020, this Court issued its Order denying AIT’s motion to lift stay. (ECF No. 116.) On May 4, 2020, RPX filed a motion with the Court of Appeals for the Federal Circuit to recall its October 2018 mandate to the PTAB, vacate its judgment (which itself vacated the PTAB’s December 2016 decisions) and reinstate the appeal which dates to 2017. AIT opposed the RPX motion on May 28, 2020, and the following day the Federal Circuit denied RPX’s motion. On April 30, 2020, RPX emailed the PTAB seeking permission to file a motion for stay in

anticipation of the motion RPX filed with the Federal Circuit on May 4. On May 5, the PTAB had a conference call with counsel and later that day issued an order authorizing RPX to file its motion for stay. On May 12, 2020 RPX filed the motion to stay the IPRs pending the Federal Circuit’s decision on RPX’s May 4, 2020 motion. On May 19, 2020 AIT opposed RPX’s motion for stay. On May 29, 2020, in response to the Federal Circuit’s denial of its motion, RPX notified the PTAB that its motion for stay was moot. The PTAB has not ruled on the motion for stay nor taken any other action with respect to RPX’s motion for stay. On July 2, 2020, the parties filed a Joint Case Status Report. (ECF No. 120). On August 3, 2020, AIT petitioned the United States Court of Appeals for the Federal Circuit for Writ of Mandamus to the PTAB. In its petition, AIT requested an expanded PTAB panel and a final decision from the PTAB in 30 days. On August 3, 2020, the Federal Circuit ordered responses to AIT’s petition from the Director of the USPTO and from RPX. On August 11, 2020, the Federal Circuit granted AIT’s withdrawal of its Petition for Writ of Mandamus based upon agreement of the USPTO that the PTAB will issue decisions in the three

IPRs on or before September 9, 2020. On September 9, 2020, the PTAB issued a decision under seal terminating the IPRs. In its decision, the PTAB determined Salesforce was a real party-in- interest to the IPRs and, accordingly, that RPX’s petitions were time-barred under 35 U.S.C. § 315(b). On October 2, 2020, the PTAB issued a public version of its decision. On October 9, 2020, RPX filed a request for rehearing of the PTAB’s decision terminating the IPRs. On October 13, 2020, AIT filed a Notice of Decision by the Patent Trial and Appeal Board. (ECF No. 127). On October 23, 2020, AIT filed its response to RPX’s rehearing request. On October 30, 2020, RPX filed its reply brief in support of its rehearing request. On November 2, 2020, AIT filed a Motion to Lift Stay of the instant proceedings. (ECF

Free access — add to your briefcase to read the full text and ask questions with AI

Applications in Internet Time, LLC v. Salesforce, Inc., (D. Nev. 2021).

Applications in Internet Time, LLC v. Salesforce, Inc. (Applications in Internet Time, LLC v. Salesforce, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Becton, Dickinson & Co. v. Tyco Healthcare Group, LP
616 F.3d 1249 (Federal Circuit, 2010)
Barton v. Clancy
632 F.3d 9 (First Circuit, 2011)
Kara Technology Inc. v. stamps.com Inc.
582 F.3d 1341 (Federal Circuit, 2009)
Young v. Lumenis, Inc.
492 F.3d 1336 (Federal Circuit, 2007)
Collegenet, Inc. v. Applyyourself, Inc.
418 F.3d 1225 (Federal Circuit, 2005)
Powell v. Home Depot U.S.A., Inc.
663 F.3d 1221 (Federal Circuit, 2011)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Aventis Pharma S.A. v. Hospira, Inc.
675 F.3d 1324 (Federal Circuit, 2012)
United States v. Maurice L. Ziegler
1 F.3d 1044 (Tenth Circuit, 1993)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
O1 Communique Laboratory, Inc. v. Logmein, Inc.
687 F.3d 1292 (Federal Circuit, 2012)
3m Innovative Properties v. Tredegar Corporation
725 F.3d 1315 (Federal Circuit, 2013)
Ortega-Candelaria v. Johnson & Johnson
755 F.3d 13 (First Circuit, 2014)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)